Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Damek

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Cancer|April 8, 2022
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart reviewKatherine Belanger, Timothy H Ung, Denise Damek, et al.
Clinical Lung Cancer|June 5, 2014
EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapySeerat Poonia, Eamon M Berge, Dara L Aisner, et al.
Journal of Neuro-Oncology|October 26, 2012
Anaplastic PXA in adults: case series with clinicopathologic and molecular featuresYao Schmidt, B K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Neuro-Oncology|April 4, 2003
NeurolymphomatosisJoachim M Baehring, Denise Damek, Emily C Martin, et al.
Cureus|March 24, 2026
Monitoring the Response of a Pineal Parenchymal Tumor of Intermediate Differentiation With Cerebrospinal Fluid Dissemination Using a Circulating Tumor Cell AssayMatthew Pelletier, B K Kleinschmidt-Demasters, Perry Corkos, et al.
CNS Oncology|September 16, 2016
A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastomaJohn Trusheim, Erin Dunbar, James Battiste, et al.
Journal of Neuro-Oncology|April 30, 2015
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trialsJulie A Carlson, Krishna Reddy, Laurie E Gaspar, et al.
Neurosurgery|April 5, 2018
The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary GlioblastomaTimothy H Ung, Douglas E Ney, Denise Damek, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Cancer|April 8, 2022
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart reviewKatherine Belanger, Timothy H Ung, Denise Damek, et al.
Clinical Lung Cancer|June 5, 2014
EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapySeerat Poonia, Eamon M Berge, Dara L Aisner, et al.
Journal of Neuro-Oncology|October 26, 2012
Anaplastic PXA in adults: case series with clinicopathologic and molecular featuresYao Schmidt, B K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Neuro-Oncology|April 4, 2003
NeurolymphomatosisJoachim M Baehring, Denise Damek, Emily C Martin, et al.
Cureus|March 24, 2026
Monitoring the Response of a Pineal Parenchymal Tumor of Intermediate Differentiation With Cerebrospinal Fluid Dissemination Using a Circulating Tumor Cell AssayMatthew Pelletier, B K Kleinschmidt-Demasters, Perry Corkos, et al.
CNS Oncology|September 16, 2016
A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastomaJohn Trusheim, Erin Dunbar, James Battiste, et al.
Journal of Neuro-Oncology|April 30, 2015
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trialsJulie A Carlson, Krishna Reddy, Laurie E Gaspar, et al.
Neurosurgery|April 5, 2018
The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary GlioblastomaTimothy H Ung, Douglas E Ney, Denise Damek, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Pageof 2